BEAM vs DD · rev $63.5M vs P/E 127, rev $12.39B
Beam Therapeutics Inc (BEAM) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
BEAM currently screens at market cap $2.01B. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the BEAM and DD stock pages for the full models.
Not investment advice.